Thoughts from the Centre

Healthcare in Thoughts from the Centre

Realising AI’s potential in the NHS: Is the NHS clear what problems it’s trying to solve?

By Karen Taylor, Director, Centre for Health Solutions

CFHS

There is understandably an ever-increasing focus on the potential of AI to transform NHS services, with a heightened expectation of its potential to boost productivity but also to improve the quality of patient care and relieve staff from burdensome administrative tasks. This expectation is not only vested in more advanced technologies like GenAI, but also in proven technologies like robotic process automation (RPA) and machine learning (ML).  Our first blog of 2025, NHS productivity: what is the current situation and how might the new NHS plan tackle this? noted that commercial digital and AI solutions are expected to drive productivity improvements. This week’s blog considers the conditions necessary to optimise the potential of AI solutions and the importance of being clear what problem the NHS wants AI to solve?

Continue reading

Posted on 03/02/2025 | 0 Comments

LSHC cut of the Deloitte 2024 CxO Sustainability report: Organisations are increasingly investing in efforts to prioritise a low carbon future

By Marcia Costa, Manager, and Karen Taylor, Director, Deloitte Centre for Health Solutions

Lshc-out-banner

Our Deloitte 2024 CxO Sustainability Report: Signs of a shift in business climate action’, published in September 2024, was the third consecutive year that Deloitte has surveyed global CxOs on their views and efforts on climate change. The survey conducted between May and June 2024, received responses from over 2,100 executives across 27 Countries, 396 were from life sciences and health (LSHC) organisations. The 2024 analysis found a notable increase in investment in sustainability efforts, and in the words of Deloitte’s Global Sustainability Leader, Jennifer Steinman, ‘early but critical indicators that executives are realising profound business opportunities in the transition to a low-emissions future’. As we did for the 2023 global report, the Centre for Health Solutions has analysed the responses from LSHC executives, to explore the extent to which the LSHC industry’s position has changed and how this varies from the overall global response. This week’s blog explores our findings.

Continue reading

Posted on 17/01/2025 | 0 Comments

NHS productivity: what is the current situation and how might the new NHS plan tackle this?

By Karen Taylor, Director, Centre for Health Solutions

5Untitled-5

In September 2024, Lord Darzi published the results of a quick and incisive review into the state of the NHS and concluded that the NHS was ’in serious trouble’.1 His report explores how we arrived at this point and identifies some key remedies. In response the Government announced its intention to develop a 10-year plan to ‘fix the NHS’ which will be published in May 2025. The start of 2025 has heralded numerous government announcements including the publication of an Elective reform plan aimed at ‘returning to the constitutional standard of 92 per cent of patients receiving treatment within 18 weeks and building a sustainable NHS that is fit for the future’.2 While the plan identifies many challenges, the need to improve NHS productivity is emphasised throughout, which reflects the findings in the Darzi review. This week’s blog focuses on analysing what has been happening to NHS productivity and what more can be done?

 

Continue reading

Posted on 13/01/2025 | 0 Comments

2025 life sciences outlook: top priorities and insights

By Karen Taylor, Director, Centre for Health Solutions

20-12-2024

A Deloitte survey of global life sciences (LS) executives conducted in 2024 finds that despite potential disruptions that could reshape the LS industry in 2025, 75 per cent of respondents are optimistic about the year ahead. This optimism is driven by strong growth expectations and a belief that advancements in science and technology could lead to more breakthrough innovations. This survey forms the backdrop to the Deloitte US Center for Health Solutions global 2025 life sciences outlook report highlighting the industry's top priorities and insights. This week’s blog explores these priorities and key insights including the role of digital transformation in driving more change in 2025.

Continue reading

Posted on 20/12/2024 | 0 Comments

Despite quantum computing's slow start, LSHC organisations need to prepare now!

By Karen Taylor, Director, Centre for Health Solutions

Lifesciences-typepad

At a recent presentation of our Life Sciences and Healthcare (LSHC) Predictions 2030 report, I fielded a question about quantum computing on when we might expect it to become a reality. My initial response based on research for the predictions report was that the quantum computing market is expected to grow significantly over the next five years as recent quantum breakthroughs have increased its potential to solve problems currently considered insurmountable. Indeed, our prediction ‘Interdependent innovations in science and technology reshaping treatment paradigms’ suggests that quantum computing together with advances in neurotechnology, will revolutionise neurology over the next five years. Another use case in LSHC is turbo charging early-stage drug discovery to bring innovation to the market sooner. But I also admitted I didn’t know enough about it and promised to do some further research and share our findings via our weekly blog. I therefore tapped into Deloitte’s and other secondary research to derive some insights.

Continue reading

Posted on 13/12/2024 | 0 Comments

How are life sciences and healthcare employees using Generative AI tools in work, approved or not?

By Márcia Costa, Manager, Centre for Health Solutions

Life-sciences-and-healthcare

GenAI is poised to change the future of work, by automating tasks, but also in unlocking flexibility, creativity and innovation. As we identified in our Accelerating the future: Life Sciences and healthcare predictions 2030 report, GenAI offers a range of opportunities to enhance the activities of most life sciences and healthcare (LSHC) employees. In October 2024, Deloitte published European trust in gen AI based on a survey of 30,252 consumers and employees on the current use and potential impact of these tools. A subset of questions addressed employees use of GenAI in the workplace, including 1,741 respondents from LSHC industries. This weeks’ blog explores how LSHC employees in Europe are using GenAI tools in their workplace (with or without their company’s approval), their expectations as to how these tools might make their work more enjoyable and productive, and the current lack of access, guidance and training that risks undermining the use of, and trust in, these tools.

Continue reading

Posted on 06/12/2024 | 0 Comments

Sepsis: Time to Act

By Emily May, Manager, Centre for Health Solutions

 

Time-to-act-banner

I recently had the honour of attending the UK Sepsis Trust’s (UKST) impactful ‘Sepsis: Time to Act’ annual event. The event brought together healthcare professionals (HCPs), passionate advocates and sepsis survivors and their support networks, to raise awareness and incite action to reduce the impact of sepsis. From the informative presentations to the shared personal stories, I was struck by the urgency and importance of addressing sepsis head-on. I’m therefore using this week’s blog to share my key takeaways from the event in order to help amplify UKST’s call to action and continue to raise awareness of, and share solutions to, the scale and impact of sepsis.

Continue reading

Posted on 03/12/2024 | 0 Comments

Beyond the statistics: How positive role models can improve men's health

By Márcia Costa, Manager, Deloitte Centre for Health Solutions

Lshc-nov22

International Men's Day (IMD), celebrated annually on 19 November, celebrates the positive impact men have on society and emphasises the importance of maintaining health and wellbeing. Its aim is to provide a platform to discuss critical issues like men’s mental health, challenge stereotypes, promote gender equality, and create a safer, better world. Importantly it also aims to raise awareness of the unique health and social challenges that men face. In the UK, like most high-income countries, men still have a shorter life expectancy than women, with higher rates of heart disease, cancer, and suicide. This year’s theme for IMD is ‘Positive Male Role Models’. In this week’s blog we explore some of the health issues and barriers to accessing care men face in the UK and how positive male role models can improve men’s health and well-being.

Continue reading

Posted on 22/11/2024 | 0 Comments

Smart manufacturing, digital supply chains may help pharma boost value

By Laks Pernenkil, principal and practice leader, Deloitte Consulting LLP

Smart-typepad-blog

The potential of AI and digital transformation to revolutionise the complex, global and interconnected pharma supply chain is vast, but, as yet, scaled adoption remains elusive. As we explored in our ‘Intelligent drug supply chain: Creating value from AI’ 2020 report, AI-powered technologies have the potential to analyse the vast amount of data from the complex chain, enabling real-time decision making, boosting efficiency, and increasing cost-effectiveness. Indeed, we found that many companies were investing in digital technologies, but were yet making consistent, sustained and bold moves to take advantage of the capabilities at scale. This week’s blog, which first appeared as a Center for Health Solution’s Health Forward blog, explores how, four years on, while some companies have started to shift from legacy manufacturing to smart manufacturing processes and adopt digital supply chains, achieving this at scale is still a challenge. The blog therefore provides crucial insights on the organisational and cultural changes needed to achieve this shift.

Continue reading

Posted on 15/11/2024 | 0 Comments

2025 outlook for US life sciences and health care: Consumers and convergence could disrupt the status quo

By Kulleni Gebreyes, M.D., vice chair and US Life Sciences & Health Care Industry leader, Deloitte

Outlook-typepad

Our ten life sciences and healthcare predictions 2030 which we launched over the past five or so weeks explore the potential changes that the life science and healthcare sectors are likely to experience over the next five years. One of the key drivers for these changes is the need to address changing consumer expectations for more convenient, affordable, personalised care. Persistent long wait times and access and equity challenges highlight a growing disconnect between consumer needs and the services offered by traditional healthcare models. This week’s blog, which first appeared as a Center for Health Solution’s Health Forward blog, is by Deloitte’s new US Life Sciences and Health Care leader, Kulleni Gebreyes, M.D., explores how innovative life sciences and healthcare organisations could address these challenges through strategic cross-industry collaborations and convergence across different sectors and industries. While this blog is focused on the experience of US health care consumers, there are lessons for many other healthcare systems.

Continue reading

Posted on 08/11/2024 | 0 Comments